doc. MUDr. Barbora Weinbergerová, Ph.D.
Department of Internal Medicine, Hematology and Oncology
phone: | +420 532 23 2214, 3603 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 135
2023
-
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use
Annals of hematology, year: 2023, volume: 102, edition: 12, DOI
-
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
International Journal of Antimicrobial Agents, year: 2023, volume: 62, edition: 4, DOI
-
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
EClinicalMedicine, year: 2023, volume: 58, edition: April 2023, DOI
-
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Frontiers in immunology, year: 2023, volume: 14, edition: February 2023, DOI
-
P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response.
Year: 2023, type: Conference abstract
-
SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report
Journal of Investigational Allergology and Clinical Immunology, year: 2023, volume: 33, edition: 3, DOI
-
Single cell analýza u pacientů s akutní myeloidní leukemií
Year: 2023, type: Conference abstract
-
The role of clonal hematopoiesis variants in the development of myeloid neoplasms post cytotoxic therapy - case series.
Year: 2023, type: Conference abstract
2022
-
B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)
Frontiers in Oncology, year: 2022, volume: 12, edition: October 2022, DOI
-
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
Blood advances, year: 2022, volume: 6, edition: 7, DOI